RegentAtlantic Capital’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$246K Buy
+8,652
New +$296K 0.01% 598
2022
Q2
Sell
-4,817
Closed -$237K 716
2022
Q1
$237K Sell
4,817
-458
-9% -$24.2K 0.01% 627
2021
Q4
$294K Buy
5,275
+33
+0.6% +$1.81K 0.01% 577
2021
Q3
$304K Sell
5,242
-500
-9% -$30.8K 0.01% 554
2021
Q2
$363K Sell
5,742
-1,044
-15% -$68.8K 0.01% 494
2021
Q1
$433K Sell
6,786
-970
-13% -$56.3K 0.01% 403
2020
Q4
$406K Sell
7,756
-8,900
-53% -$439K 0.02% 372
2020
Q3
$728K Buy
16,656
+6,197
+59% +$274K 0.03% 275
2020
Q2
$461K Sell
10,459
-1,062
-9% -$44.9K 0.03% 317
2020
Q1
$447K Sell
11,521
-2,282
-17% -$116K 0.03% 283
2019
Q4
$781K Buy
13,803
+9,292
+206% +$518K 0.05% 266
2019
Q3
$240K Buy
+4,511
New +$242K 0.02% 394
2018
Q3
Sell
-4,791
Closed -$210K 443
2018
Q2
$210K Hold
4,791
0.02% 388
2018
Q1
$241K Sell
4,791
-1,008
-17% -$59.4K 0.02% 380
2017
Q4
$382K Buy
5,799
+108
+2% +$6.87K 0.03% 322
2017
Q3
$340K Hold
5,691
0.03% 325
2017
Q2
$369K Sell
5,691
-110
-2% -$6.95K 0.03% 307
2017
Q1
$362K Hold
5,801
0.03% 308
2016
Q4
$335K Sell
5,801
-219
-4% -$12.9K 0.03% 311
2016
Q3
$358K Hold
6,020
0.04% 304
2016
Q2
$373K Sell
6,020
-104
-2% -$6.4K 0.04% 292
2016
Q1
$377K Buy
6,124
+307
+5% +$18.1K 0.04% 285
2015
Q4
$354K Sell
5,817
-201
-3% -$12K 0.04% 293
2015
Q3
$304K Sell
6,018
-400
-6% -$21.3K 0.03% 311
2015
Q2
$331K Sell
6,418
-260
-4% -$13.5K 0.03% 299
2015
Q1
$340K Sell
6,678
-63
-0.9% -$3.25K 0.03% 292
2014
Q4
$359K Sell
6,741
-270
-4% -$13.7K 0.03% 289
2014
Q3
$320K Buy
7,011
+605
+9% +$28.5K 0.03% 296
2014
Q2
$303K Buy
6,406
+460
+8% +$21.4K 0.03% 303
2014
Q1
$274K Hold
5,946
0.03% 303
2013
Q4
$288K Hold
5,946
0.03% 302
2013
Q3
$258K Sell
5,946
-205
-3% -$8.75K 0.03% 300
2013
Q2
$252K Buy
+6,151
New +$256K 0.03% 292

Other funds holding XRAY

RegentAtlantic Capital's XRAY Position: Q3 2022 in Review

RegentAtlantic Capital opened a new position in Dentsply Sirona (XRAY) in Q3 2022: 8,652 shares worth $246K. The stake represents 0.01% of the portfolio and ranks #598 among its holdings. This is a return to the name: RegentAtlantic Capital previously reported a position in XRAY as recently as Q1 2022.

RegentAtlantic Capital first reported a position in XRAY in Q2 2013 and has held it in 33 quarters since. The position peaked at $781K in Q4 2019. 460 funds tracked by Wall St. Rank hold XRAY as of Q3 2022.

  • RegentAtlantic Capital held 8,652 shares of Dentsply Sirona worth $246K as of Q3 2022.
  • Dentsply Sirona was a new RegentAtlantic Capital position in Q3 2022.
  • Dentsply Sirona made up 0.01% of RegentAtlantic Capital's portfolio in Q3 2022, its #598 holding.
  • RegentAtlantic Capital first reported a position in Dentsply Sirona in Q2 2013 and has held it in 33 quarters since.
  • RegentAtlantic Capital's Dentsply Sirona position peaked at $781K in Q4 2019.
  • 460 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.